Letter to the Editor
Enzyme replacement therapy in Fabry disease: Towards a better understanding of the implications of antibody formation and dose

https://doi.org/10.1016/j.ymgme.2008.08.006Get rights and content

References (23)

  • P.D. Whitfield et al.

    Monitoring enzyme replacement therapy in Fabry disease—role of urine globotriaosylceramide

    J. Inherit. Metab. Dis.

    (2005)
  • View full text